There is evidence that BRCA1 modifies estrogen-mediated tumor progression, as increased E2-ER signal accelerate preneoplasia and cancer development in the absences of BRCA1, favoring breast de-differentiation and tumorigenesis (51, 52). The gene discussed is BRCA1; the disease is neoplasm.